Jim Simons’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-1,957,600
| Closed | -$35.1M | – | 3742 |
|
|
2017
Q4 | $35.1M | Buy |
1,957,600
+651,900
| +50% | +$8.03M | 0.04% | 608 |
|
|
2017
Q3 | $15.4M | Buy |
1,305,700
+495,100
| +61% | +$5.55M | 0.02% | 1055 |
|
|
2017
Q2 | $8.51M | Sell |
810,600
-300,800
| -27% | -$3.07M | 0.01% | 1376 |
|
|
2017
Q1 | $12.2M | Sell |
1,111,400
-348,400
| -24% | -$4.04M | 0.02% | 1109 |
|
|
2016
Q4 | $19.8M | Buy |
1,459,800
+106,800
| +8% | +$1.49M | 0.03% | 792 |
|
|
2016
Q3 | $16.7M | Buy |
1,353,000
+245,300
| +22% | +$2.89M | 0.03% | 814 |
|
|
2016
Q2 | $12.2M | Buy |
1,107,700
+282,000
| +34% | +$3.16M | 0.02% | 1016 |
|
|
2016
Q1 | $9.03M | Buy |
825,700
+270,900
| +49% | +$3.42M | 0.02% | 1216 |
|
|
2015
Q4 | $9.59M | Buy |
554,800
+112,700
| +25% | +$2.02M | 0.02% | 1018 |
|
|
2015
Q3 | $8.79M | Buy |
442,100
+108,000
| +32% | +$2.48M | 0.02% | 1015 |
|
|
2015
Q2 | $5.49M | Buy |
334,100
+110,386
| +49% | +$1.91M | 0.01% | 1379 |
|
|
2015
Q1 | $3.48M | Buy |
223,714
+164,914
| +280% | +$2.56M | 0.01% | 1596 |
|
|
2014
Q4 | $840K | Buy |
+58,800
| New | +$621K | ﹤0.01% | 2208 |
|
|
2014
Q1 | – | Sell |
-36,000
| Closed | -$338K | – | 3132 |
|
|
2013
Q4 | $338K | Sell |
36,000
-91,800
| -72% | -$655K | ﹤0.01% | 2475 |
|
|
2013
Q3 | $797K | Sell |
127,800
-107,200
| -46% | -$670K | ﹤0.01% | 2110 |
|
|
2013
Q2 | $1.55M | Buy |
+235,000
| New | +$1.86M | ﹤0.01% | 1724 |
|
Other funds holding SCMP
Jim Simons's SCMP Position: Q1 2018 in Review
Jim Simons sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 1,957,600 shares — an estimated $35.1M sold.
Jim Simons first reported a position in SCMP in Q2 2013 and held it in 16 quarters. The position peaked at $35.1M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.
- Jim Simons reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
- Jim Simons sold 1,957,600 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $35.1M.
- Jim Simons first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 16 quarters.
- Jim Simons's Sucampo Pharmaceuticals, Inc. position peaked at $35.1M in Q4 2017.
- 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.
Based on Renaissance Technologies's 13F filing for Q1 2018, filed 14 May 2018.